Beatriz Sicilia

2.2k total citations
50 papers, 766 citations indexed

About

Beatriz Sicilia is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Beatriz Sicilia has authored 50 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Genetics, 33 papers in Epidemiology and 22 papers in Surgery. Recurrent topics in Beatriz Sicilia's work include Inflammatory Bowel Disease (36 papers), Microscopic Colitis (29 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Beatriz Sicilia is often cited by papers focused on Inflammatory Bowel Disease (36 papers), Microscopic Colitis (29 papers) and Helicobacter pylori-related gastroenterology studies (9 papers). Beatriz Sicilia collaborates with scholars based in Spain, Chile and Switzerland. Beatriz Sicilia's co-authors include Fernando Gomollón, Joaquín Hinojosa, Javier P. Gisbert, Santiago García‐López, María José Revillo, Julio Ducóns, Raquel Vicente, Albert Villòria, Xavier Calvet and Ignacio Marín‐Jiménez and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Gastroenterology and Medicine.

In The Last Decade

Beatriz Sicilia

47 papers receiving 749 citations

Peers

Countries citing papers authored by Beatriz Sicilia

Since Specialization

Citations

This map shows the geographic impact of Beatriz Sicilia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Sicilia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Sicilia more than expected).

Fields of papers citing papers by Beatriz Sicilia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Sicilia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Sicilia. The network helps show where Beatriz Sicilia may publish in the future.

Co-authorship network of co-authors of Beatriz Sicilia

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz Sicilia. A scholar is included among the top collaborators of Beatriz Sicilia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz Sicilia. Beatriz Sicilia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	P516 Subcutaneous infliximab cut-off points in a large cohort of Spanish patients with inflammatory bowel disease and factors associated with long-term outcomes 2024 ·Journal of Crohn s and Colitis ·Marisa Iborra, Berta Caballol, António Garrido, José María Huguet, Francisco Mesonero, Ángel Ponferrada, (unknown), Marta Maia Boscá-Watts, (unknown), Eduard Brunet‐Mas, Ana Gutiérrez, Íngrid Ordás, (unknown), (unknown), (unknown), Beatriz Sicilia, Elena Ricart, Pilar Nos	2
2	IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management 2024 ·Digestive Diseases and Sciences ·Pablo Vega, José María Huguet, Ernesto A. Gómez, Saioa Rubio Iturria, (unknown), (unknown), José María Rubio Paredes, Alejandro Hernández-Camba, (unknown), Míriam Mañosa, Ramón Pajares, Beatriz Sicilia, (unknown), (unknown), Christoph Leitner, (unknown), (unknown), (unknown), Axel Dignaß, Fernando Gomollón	6
3	Low risk of new dysplastic lesions in an inflammatory bowel disease population study with dye chromoendoscopy 2023 ·SHILAP Revista de lepidopterología ·Beatriz Sicilia, Yago González‐Lama, Benito Velayos, (unknown), (unknown), (unknown), Luis Hernández, (unknown), (unknown), Luis Fernández‐Salazar, (unknown), Jésus Barrio, Fernándo Muñoz, Lara Arias	0
4	Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain 2022 ·Therapeutic Advances in Gastroenterology ·Federico Argüelles‐Arias, Fernando Bermejo, Joaquín Borrás‐Blasco, Eugeni Domènech, Beatriz Sicilia, José María Huguet, Antonio Ramírez de Arellano, William J. Valentine, Barnaby Hunt	1
5	Incidencia e historia natural de la enfermedad inflamatoria intestinal en Castilla y León: estudio prospectivo, multicéntrico y poblacional 2022 ·Gastroenterología y Hepatología ·(unknown), Jésus Barrio, Luis Fernández‐Salazar, Lara Arias, (unknown), (unknown), Ana Fuentes Coronel, (unknown), (unknown), (unknown), (unknown), (unknown), Alejandro Núñez, (unknown), (unknown), Luis Hernández, Beatriz Sicilia	2
6	Recommendations of the Spanish Working Group on Crohn’s disease and Ulcerative Colitis (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa — GETECCU) on dysplasia screening in inflammatory bowel disease patients 2021 ·Gastroenterología y Hepatología (English Edition) ·Beatriz Sicilia, Raquel Vicente, Lara Arias, Ana Echarri, Yamile Zabana, Míriam Mañosa, Belén Beltrán, Manuel Barreiro‐de Acosta	1
7	Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE study 2021 ·Digestive and Liver Disease ·Guillermo Bastida, Ignacio Marín‐Jiménez, (unknown), E. García‐Planella, Federico Argüelles‐Arias, Ignacio Tagarro, (unknown), (unknown), (unknown), (unknown), (unknown), Marta Maia Boscá-Watts, Rocío Ferreiro‐Iglesias, Olga Merino, Xavier Aldeguer, Xavier Cortés, Beatriz Sicilia, Francisco Mesonero, Manuel Barreiro‐de Acosta	11
8	Are Steroids Still Useful in Immunosuppressed Patients With Inflammatory Bowel Disease? A Retrospective, Population-Based Study 2021 ·Frontiers in Medicine ·Beatriz Sicilia, Lara Arias, (unknown), (unknown), (unknown), Fernando Gomollón	8
9	Validation of a self-reported work disability questionnaire for ulcerative colitis 2018 ·Medicine ·(unknown), Mercedes Vergara, (unknown), Beatriz Sicilia, Fernando Gomollón, Xavier Calvet	0
10	Development and Validation of the Short Crohnʼs Disease Work Disability Questionnaire 2016 ·Inflammatory Bowel Diseases ·Mercedes Vergara, Beatriz Sicilia, Luís Prieto, Francesc Casellas, (unknown), Fernando Gomollón, Xavier Calvet	7
11	Ustekinumab for the Treatment of Refractory Crohnʼs Disease 2016 ·Inflammatory Bowel Diseases ·Sam Khorrami, Daniel Ginard, Ignacio Marín‐Jiménez, María Chaparro, Mónica Sierra, Mariam Aguas, Beatriz Sicilia, Valle García-Sánchez, Cristina Suárez-Mejías, Albert Villòria, Carlos Taxonera, (unknown), (unknown), Javier P. Gisbert	124
12	IBD‐related work disability in the community: Prevalence, severity and predictive factors. A cross‐sectional study 2015 ·United European Gastroenterology Journal ·(unknown), Xavier Calvet, Beatriz Sicilia, Mercedes Vergara, Ariadna Figuerola, (unknown), (unknown), Albert Villòria, Fernando Gomollón	35
13	Delphi consensus statement: Quality indicators for Inflammatory Bowel Disease Comprehensive Care Units 2013 ·Journal of Crohn s and Colitis ·Xavier Calvet, Julián Panés, (unknown), Joaquín Hinojosa, Beatriz Sicilia, Marta Gallego, (unknown), Pablo Mercado, Fernando Gomollón	76
14	Risk factors for ulcerative colitis: A population-based, case–control study in Spain 2008 ·Journal of Crohn s and Colitis ·Beatriz Sicilia, (unknown), Juan P. Barret, (unknown), Raquel Vicente, Fernando Gomollón	11
15	La afectación pancolónica inicial en la colitis ulcerosa predice la necesidad de colectomía: estudio poblacional basado en una cohorte incidente de pacientes en Aragón 2005 ·Gastroenterología y Hepatología ·Beatriz Sicilia, Raquel Vicente, M Arroyo, (unknown), Fernando Gomollón	11
16	Resistencia de Helicobacter pylori al metronidazol y a la claritromicina: análisis descriptivo entre 1997 y 2000 2004 ·Medicina Clínica ·Fernando Gomollón, Santos Santolaria, Beatriz Sicilia, (unknown), María José Revillo, Julio Ducóns, (unknown), (unknown), Miguel Montoro	9
17	Erradicación de Helicobacter pylori en pacientes con úlcera péptica tras fracaso de dos tratamientos previos: estudio prospectivo guiado por cultivo 2002 ·Gastroenterología y Hepatología ·Raquel Vicente, Beatriz Sicilia, (unknown), María José Revillo, Julio Ducóns, Fernando Gomollón	25
18	Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain 2001 ·Digestive and Liver Disease ·Beatriz Sicilia, (unknown), (unknown), (unknown), (unknown), Fernando Gomollón	32
19	Helicobacter pylori: strategies for treatment 2001 ·Expert Opinion on Investigational Drugs ·Fernando Gomollón, Beatriz Sicilia	4
20	Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period 2000 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), Beatriz Sicilia, Santos Santolaria, (unknown), Fernando Gomollón	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact